Compound ID | 616
Class: Macrolide
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Sphingomyelin phosphodiesterase inhibitors; low activity against bacteriodes and other anaerobes |
Institute where first reported: | Daiichi Sankyo Pharmaceutical, Japan |
Year first mentioned: | 1986 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Reason Dropped: | Very low potency to tested bacteria |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/10019526 |
Guide to Pharmacology: | Macquarimicin A |
Citations: |
|